Digital Patient Recruitment Patient Recruitment Insights
What the ISCHEMIA Controversy Tells Us About Patient Recruitment in Clinical Trials
Patient recruitment difficulties in a key NIH study demonstrate widespread need for improved enrollment pipelines.
Minority Patients Underrepresented in Clinical Trials – But They Want to Participate
Effective clinical trials rely on diverse patient populations. So why are minority participants consistently underrepresented?
AI, mHealth Adoption in Clinical Trials Remains Slow
Patient recruitment and retention for clinical trials have always been difficult, but AI and mHealth can help – if sponsors and CROs are willing to invest…
New Study Highlights Pros and Cons of Using Social Media for Clinical Trial Recruitment
Though the medium presents a few unique challenges, clinical trials stand to recruit new patients and reduce costs through social media.
How Digital Marketing Helps Clinical Trials Get Better Results from Investigator Sites
Learn how to use digital ad campaigns as a safety net for struggling investigator sites.
New Clinical Trial Patient Recruitment Best Practices for 2018
Struggling with patient recruitment and retention? Ring in the new year with these best practices for clinical trial marketing.
FDA Says Clinical Trials Are Too Confusing – Even for Doctors
If doctors and nurses don’t understand basic clinical trial information, why would they refer their patients?
Want to Recruit More Prospective Patients for Your Clinical Trial? Start Advertising on Facebook
Facebook’s large and highly relevant audience make it an ideal platform for digital clinical trial recruitment.
Overcoming Clinical Trial Recruitment Obstacles With Digital Advertising
As patients become increasingly empowered, sponsors and CROs need to update their recruitment tactics accordingly.
Digital Disconnect: Why Won’t Clinical Trials Embrace Online Advertising?
Clinical trial recruiters have been slow to adopt digital advertising best practices, leading to longer enrollment periods and untenably high costs.